Ibrutinib-related stellar hematomas of the palms and soles
- PMID: 39485009
- DOI: 10.1002/ajh.27514
Ibrutinib-related stellar hematomas of the palms and soles
References
REFERENCES
-
- Sibaud V, Beylot‐Barry M, Protin C, Vigarios E, Recher C, Ysebaert L. Dermatological toxicities of Bruton's tyrosine kinase inhibitors. Am J Clin Dermatol. 2020;21(6):799‐812.
-
- Singer S, Tan SY, Dewan AK, et al. Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor–induced dermatologic adverse events. J Am Acad Dermatol. 2023;88(6):1271‐1281.
-
- Nocco S, Andriano TM, Bose A, et al. Ibrutinib‐associated dermatologic toxicities: a systematic review and meta‐analysis. Crit Rev Oncol Hematol. 2022;174:103696.
-
- Pileri A, Guglielmo A, Agostinelli C, et al. Cutaneous adverse‐events in patients treated with ibrutinib. Dermatol Ther. 2020;33(6):e14190.
-
- Levade M, David E, Garcia C, et al. Ibrutinib treatment affects collagen and von Willebrand factor‐dependent platelet functions. Blood. 2014;124(26):3991‐3995.
Publication types
LinkOut - more resources
Full Text Sources
